tiprankstipranks
Vivos Therapeutics price target lowered to $6 from $8.25 at Alliance Global Partners
PremiumThe FlyVivos Therapeutics price target lowered to $6 from $8.25 at Alliance Global Partners
3M ago
Vivos Therapeutics Reports Revenue Growth and Strategic Milestones
Premium
Company Announcements
Vivos Therapeutics Reports Revenue Growth and Strategic Milestones
3M ago
VVOS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VVOS Earnings this Week: How Will it Perform?
3M ago
Morning Movers: General Mills dips following Q2 report
PremiumThe FlyMorning Movers: General Mills dips following Q2 report
5M ago
Vivos receives FDA 510k clearance to treat pediatric sleep apnea, snoring
Premium
The Fly
Vivos receives FDA 510k clearance to treat pediatric sleep apnea, snoring
5M ago
Vivos Therapeutics Enhances Incentives and Executive Pay Structure
Premium
Company Announcements
Vivos Therapeutics Enhances Incentives and Executive Pay Structure
5M ago
option delistings on June 3rd
PremiumThe Flyoption delistings on June 3rd
9M ago
Vivos Therapeutics reports Q1 EPS ($1.63), consensus ($1.17)
Premium
The Fly
Vivos Therapeutics reports Q1 EPS ($1.63), consensus ($1.17)
9M ago
Vivos Therapeutics, Inc. (VVOS) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Vivos Therapeutics, Inc. (VVOS) Q1 Earnings Cheat Sheet
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100